Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
NCT ID: NCT07276087
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-09-11
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This observational, case-control study aims to compare multiple physical and psychosocial parameters among individuals with Takayasu arteritis, Behçet's disease, and healthy controls. Assessments will include respiratory and peripheral muscle strength, functional status, exercise capacity, body composition, quality of life, illness perception, and psychological well-being. Measurements will be conducted using standardized clinical tests (such as maximal inspiratory and expiratory pressures, handgrip and limb strength dynamometry, squat test, and six-minute walk test) and validated questionnaires (Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS)).
The study seeks to identify differences between groups and provide a comprehensive understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical performance, quality of life, and psychosocial health. These findings may help guide physiotherapy, rehabilitation, and multidisciplinary management strategies for patients with systemic vasculitis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombophilia and Thrombosis in Behçet's Disease
NCT06451575
The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease
NCT01720628
Withdrawal of Colchicine in Behçet Syndrome
NCT06146192
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies have reported reduced physical performance, fatigue, and impaired quality of life in patients with systemic vasculitis. However, there is limited evidence directly comparing physical and psychosocial parameters between individuals with Takayasu arteritis, Behçet's disease, and healthy controls. The current literature lacks a comprehensive approach addressing the multidimensional impact of these diseases on functional and psychological outcomes.
This observational, cross-sectional study aims to fill this gap by evaluating and comparing respiratory and peripheral muscle strength, functional capacity, quality of life, illness perception, and related psychosocial parameters among these three groups. Measurements will include maximal inspiratory and expiratory pressures, handgrip and limb muscle strength via digital dynamometry, functional tests such as the squat test and the six-minute walk test, and standardized self-reported questionnaires including the Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS).
The study is expected to provide a multidimensional understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical and psychosocial functioning. The findings are anticipated to contribute to the literature by highlighting differences between disease groups and healthy controls and to guide future physiotherapy and rehabilitation strategies aimed at improving overall health and quality of life in individuals with systemic vasculitis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Takayasu Arteritis Group
Participants diagnosed with Takayasu arteritis according to established clinical and imaging criteria.
No intervention (observational study)
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Behçet's Disease Group
Participants diagnosed with Behçet's disease according to the International Study Group criteria.
No intervention (observational study)
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Healthy Control Group
Age- and sex-matched healthy volunteers with no systemic or chronic disease.
No intervention (observational study)
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention (observational study)
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Takayasu arteritis according to the American College of Rheumatology (ACR) classification criteria.
* Voluntary participation with written informed consent.
* Age 18 years or older.
* Diagnosis of Behçet's disease according to the International Study Group for Behçet's Disease criteria.
* Voluntary participation with written informed consent.
* Age 18 years or older.
* No history of systemic, rheumatologic, or chronic inflammatory disease.
* Voluntary participation with written informed consent.
Exclusion Criteria
* Presence of psychiatric disorder or ongoing psychiatric treatment.
* Cognitive impairment that may interfere with participation.
* Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
* History of any surgical operation within the past year.
* Coexisting rheumatic disease other than Takayasu arteritis or Behçet's disease.
* Pregnancy.
* Presence of psychiatric disorder or ongoing psychiatric treatment.
* Cognitive impairment that may interfere with participation.
* Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
* History of any surgical operation within the past year.
* History of rheumatologic or chronic inflammatory disease.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pamukkale University
OTHER
Uşak University
OTHER
Alanya Alaaddin Keykubat University
OTHER
ÖZLEM NUR TOK YAMAN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ÖZLEM NUR TOK YAMAN
Lecturer , Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pamukkale University
Denizli, Denizli, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAU-KAEK-2025-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.